Literature DB >> 21375801

Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.

Jung Yeon Lim1, Sang In Park, Seong Muk Kim, Jin Ae Jun, Ji Hyeon Oh, Chung Hun Ryu, Chang Hyun Jeong, Sun Hwa Park, Soon A Park, Wonil Oh, Jong Wook Chang, Sin-Soo Jeun.   

Abstract

The ability of mesenchymal stem cells (MSCs) to differentiate into neural cells makes them potential replacement therapeutic candidates in neurological diseases. Presently, overexpression of brain-derived neurotrophic factor (BDNF), which is crucial in the regulation of neural progenitor cell differentiation and maturation during development, was sufficient to convert the mesodermal cell fate of human umbilical cord blood-derived MSCs (hUCB-MSCs) into a neuronal fate in culture, in the absence of specialized induction chemicals. BDNF overexpressing hUCB-MSCs (MSCs-BDNF) yielded an increased number of neuron-like cells and, surprisingly, increased the expression of neuronal phenotype markers in a time-dependent manner compared with control hUCB-MSCs. In addition, MSCs-BDNF exhibited a decreased labeling for MSCs-related antigens such as CD44, CD73, and CD90, and decreased potential to differentiate into mesodermal lineages. Phosphorylation of the receptor tyrosine kinase B (TrkB), which is a receptor of BDNF, was increased significantly in MSC-BDNF. BDNF overexpression also increased the phosphorylation of β-catenin and extracellular signal-regulated kinases (ERKs). Inhibition of TrkB availability by treatment with the TrkB-specific inhibitor K252a blocked the BDNF-stimulated phosphorylation of β-catenin and ERKs, indicating the involvement of both the β-catenin and ERKs signals in the BDNF-stimulated and TrkB-mediated neural differentiation of hUCB-MSCs. Reduction of β-catenin availability using small interfering RNA-mediated gene silencing inhibited ERKs phosphorylation. However, β-catenin activation was maintained. In addition, inhibition of β-catenin and ERKs expression levels abrogated the BDNF-stimulated upregulation of neuronal phenotype markers. Furthermore, MSC-BDNF survived and migrated more extensively when grafted into the lateral ventricles of neonatal mouse brain, and differentiated significantly into neurons in the olfactory bulb and periventricular astrocytes. These results indicate that BDNF induces the neural differentiation of hUCB-MSCs in culture via the TrkB-mediated phosphorylation of ERKs and β-catenin and following transplantation into the developing brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375801     DOI: 10.3727/096368910X557236

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  13 in total

Review 1.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

Review 2.  An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.

Authors:  Abhishek Kumar Singh; Mahendra Pratap Kashyap
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

Review 3.  Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play.

Authors:  Virginie Neirinckx; Cécile Coste; Bernard Rogister; Sabine Wislet-Gendebien
Journal:  Stem Cells Transl Med       Date:  2013-03-13       Impact factor: 6.940

4.  Preparation of NGF encapsulated chitosan nanoparticles and its evaluation on neuronal differentiation potentiality of canine mesenchymal stem cells.

Authors:  Bhabesh Mili; Kinsuk Das; Ajay Kumar; A C Saxena; Praveen Singh; Srikanta Ghosh; Sadhan Bag
Journal:  J Mater Sci Mater Med       Date:  2017-12-04       Impact factor: 3.896

5.  Basic Fibroblast Growth Factor Induces Cholinergic Differentiation of Tonsil-Derived Mesenchymal Stem Cells.

Authors:  Ji-Hye Song; Se-Young Oh; Sangmee Ahn Jo
Journal:  Tissue Eng Regen Med       Date:  2022-07-20       Impact factor: 4.451

6.  Neurotrophic features of human adipose tissue-derived stromal cells: in vitro and in vivo studies.

Authors:  Wanda Lattanzi; Maria Concetta Geloso; Nathalie Saulnier; Stefano Giannetti; Maria Ausiliatrice Puglisi; Valentina Corvino; Antonio Gasbarrini; Fabrizio Michetti
Journal:  J Biomed Biotechnol       Date:  2011-12-15

7.  Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.

Authors:  Guojun Chen; Yali Wang; Zhenyu Xu; Feng Fang; Renmei Xu; Yue Wang; Xiaoli Hu; Lixing Fan; Houqi Liu
Journal:  J Transl Med       Date:  2013-01-26       Impact factor: 5.531

Review 8.  Stem cell delivery of therapies for brain disorders.

Authors:  Alexander Aleynik; Kevin M Gernavage; Yasmine Sh Mourad; Lauren S Sherman; Katherine Liu; Yuriy A Gubenko; Pranela Rameshwar
Journal:  Clin Transl Med       Date:  2014-07-19

9.  Effects on Proliferation and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells Engineered to Express Neurotrophic Factors.

Authors:  Yi Wang; Youguo Ying; Xiaoyan Cui
Journal:  Stem Cells Int       Date:  2015-11-15       Impact factor: 5.443

10.  Localization of phosphotyrosine adaptor protein ShcD/SHC4 in the adult rat central nervous system.

Authors:  Hannah N Robeson; Hayley R Lau; Laura A New; Jasmin Lalonde; John N Armstrong; Nina Jones
Journal:  BMC Neurosci       Date:  2019-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.